TransMedics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

TransMedics Group, Inc. (Nasdaq: TMDX), a leader in organ transplant technology, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference. The event is scheduled for September 12, 2022, at 11:40 a.m. ET at the Sheraton New York. The management team will engage in a fireside chat, which will be accessible via a live and archived webcast on the company's investors' webpage.

TransMedics focuses on enhancing organ quality and viability assessments to improve transplant outcomes for patients with end-stage organ failure.

ANDOVER, Mass., Aug. 29, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 20^th Annual Global Healthcare Conference at the Sheraton New York. The fireside chat will take place on Monday, September 12, 2022, at 11:40 a.m. Eastern Time.

Event: Morgan Stanley 20^th Annual Global Healthcare Conference
Date: Monday, September 12, 2022
Time: 11:40 a.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.

TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-morgan-stanley-20th-annual-global-healthcare-conference-301613980.html

SOURCE TransMedics Group, Inc.

FAQ

When will TransMedics participate in the Morgan Stanley 20th Annual Global Healthcare Conference?

TransMedics will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 11:40 a.m. ET.

Where can I watch the TransMedics fireside chat?

The fireside chat will be available as a live and archived webcast on the TransMedics investors' section of their website.

What is TransMedics known for?

TransMedics is known for its innovations in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.

What is the significance of the Morgan Stanley Global Healthcare Conference for TMDX?

The Morgan Stanley Global Healthcare Conference provides TransMedics an opportunity to showcase its advancements in organ transplant technology to a global audience.